Please join PetDx at the AVMA Convention at the Colorado Convention Center.

Exhibit Hall Booth #548

Please visit our booth at the show to learn more about OncoK9, the liquid biopsy test for dogs.

Conference Program Sessions

Friday, July 14, 2023 @ 9:00 AM

• Title: B*rk Cancer! How and when is cancer detected in dogs and can we do better?
• Speaker: Todd Cohen, DVM, DACVIM (SAIM), PetDx Director of Clinical Support
• Program Description: Major veterinary medical organizations recognize the importance of early cancer detection in dogs; however, guidelines-driven screening protocols for early cancer detection are lacking, and cancer is often detected at advanced stages. Diagnosis of canine cancer at earlier stages, or at earlier substages (e.g., prior to the onset of clinical signs) has been proven to lead to better outcomes for many cancer types.  This session will examine data from over 350 cancer-diagnosed dogs to establish how the presenting complaint came to attention and led to a definitive diagnosis of cancer in these patients. Additionally, the session will review the typical age at which cancer is diagnosed in dogs from a cohort of over 3,000 cancer-diagnosed patients. Using this data, an “age to start cancer screening” can be recommended, based on an individual dog’s breed or weight. The session will conclude with a discussion of how blood-based liquid biopsy testing may offer a convenient, non-invasive screening tool to aid in the earlier identification of cancer in dogs.
• Session Code: 1529
• Session Credits: 1.00

Friday, July 14, 2023 @ 10:00 AM

• Title: When the Usual Tools Aren’t Cutting It: Use of Liquid Biopsy for the Workup of Suspected Cancer
• Speaker: Todd Cohen, DVM, DACVIM (SAIM), PetDx Director of Clinical Support
• Program Description: When a dog is suspected of having cancer, the workup can take many forms and a variety of tests may be needed to arrive at a diagnosis. One novel tool in the clinician’s toolbox is liquid biopsy, a test that evaluates a blood sample for the presence of circulating tumor DNA which indicates the current presence of cancer in the body. This session will review the basic principles of liquid biopsy testing and how this technology may be useful as an aid-in-diagnosis for cancer detection in patients for which cancer is on the differential list. A series of illustrative case samples will be presented, demonstrating how liquid biopsy has been used in the evaluation of dogs with suspected cancer.
• Session Code: 1537
• Session Credits: 1.00